Design and synthesis of 1,2,3-triazole–etodolac hybrids as potent anticancer molecules-Reference-Cited by-同舟云学术

Design and synthesis of 1,2,3-triazole–etodolac hybrids as potent anticancer molecules

Published:2017 Issue:38 Volume:7 Page:23680-23686
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Kummari Bhaskar¹²³⁴⁵^ORCID,Polkam Naveen¹²³⁴⁵,Ramesh Perla⁶⁷⁸⁵^ORCID,Anantaraju Hasithashilpa⁹¹⁰¹¹¹²⁵,Yogeeswari Perumal⁹¹⁰¹¹¹²⁵,Anireddy Jaya Shree¹²³⁴⁵,Guggilapu Sravanthi Devi¹³¹⁴¹⁵⁵,Babu Bathini Nagendra¹³¹⁴¹⁵⁵

Affiliation:

1. Centre for Chemical Sciences and Technology

2. Institute of Science and Technology

3. Jawaharlal Nehru Technological University Hyderabad

4. Hyderabad-500085

5. India

6. Natural Products Chemistry Division

7. Indian Institute of Chemical Technology

8. Hyderabad-500007

9. Department of Pharmacy

10. Birla Institute of Technology and Science

11. Pilani

12. Hyderabad Campus

13. Department of Medicinal Chemistry

14. National Institute of Pharmaceutical Education Research (NIPER)

15. Hyderabad

Abstract

A series of novel 1,2,3-triazole–etodolac hybrids (6a–l) were synthesized as potent anti-cancer molecules and the synthesis strongly relies on Huisgen's 1,3-dipolar cycloaddition between etodolac azide 3 and substituted terminal alkynes 5a–l.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/RA/C6RA28525B

Reference38 articles.

1. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation

2. American Cancer Society , Cancer Facts & Figures 2015, American Cancer Society, Atlanta, 2015

3. American Cancer Society , Cancer Facts & Figures 2014, American Cancer Society, Atlanta, 2014

4. American Cancer Society , Cancer Facts & Figures 2013, American Cancer Society, Atlanta, 2013

5. American Cancer Society , Cancer Facts & Figures 2012, American Cancer Society, Atlanta, 2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advancements in Refashioning of NSAIDs and their Derivatives as Anticancer Candidates;Current Pharmaceutical Design;2024-05

2. 1,2,3-Triazole Hybrids Containing Isatins and Phenolic Moieties: Regioselective Synthesis and Molecular Docking Studies;Molecules;2024-03-30

3. Anticancer Drug Discovery By Structure-Based Repositioning Approach;Mini-Reviews in Medicinal Chemistry;2024-01

4. Design, synthesis, and evaluation of 1,2,3‐triazole‐based benzenesulfonamide and flavonol hybrid molecules as anticancer agents;Journal of the Chinese Chemical Society;2023-08-04

5. Triazolo‐linked benzimidazoles as tubulin polymerization inhibitors and DNA intercalators: Design, synthesis, cytotoxicity, and docking studies;Archiv der Pharmazie;2023-02-17